{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:25:21Z","timestamp":1761456321164,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["461080000"],"award-info":[{"award-number":["461080000"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117343","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:44:40Z","timestamp":1758152680000},"page":"117343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Diversity of human choline transporters: substrate specificity, kinetic properties, and inhibitor sensitivity"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8442-9635","authenticated-orcid":false,"given":"Kyra-Elisa Maria","family":"Redeker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Brockm\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117343_b0005","series-title":"Presynaptic Receptors and Neuronal Transporters","first-page":"143","article-title":"Identification and Regulation of High-affinity-choline Transporter","author":"Knipper","year":"1991"},{"issue":"2","key":"10.1016\/j.bcp.2025.117343_b0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.1978.tb06530.x","article-title":"Carrier mediated blood-brain barrier transport of choline and certain choline analogs","volume":"30","author":"Cornford","year":"1978","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.bcp.2025.117343_b0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1007613326759","article-title":"Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data","volume":"17","author":"Murakami","year":"2000","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117343_b0020","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1471-4159.2001.00093.x","article-title":"Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique","volume":"76","author":"Allen","year":"2001","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nmd.2020.10.006","article-title":"Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter","volume":"31","author":"Rodr\u00edguez Cruz","year":"2021","journal-title":"Neuromusc. Disord. NMD"},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajhg.2016.06.033","article-title":"Impaired presynaptic high-affinity choline transporter causes a congenital myasthenic syndrome with episodic apnea","volume":"99","author":"Bauch\u00e9","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.117343_b0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1023\/A:1022809003997","article-title":"High-affinity choline transporter","volume":"28","author":"Okuda","year":"2003","journal-title":"Neurochem. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117343_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102265","article-title":"Functional expression of choline transporters in the blood-brain barrier","volume":"11","author":"Inazu","year":"2019","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.bcp.2025.117343_b0045","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1073\/pnas.0401667101","article-title":"Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice","volume":"101","author":"Ferguson","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117343_b0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuint.2016.03.012","article-title":"Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine","volume":"98","author":"Iwamoto","year":"2016","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.bcp.2025.117343_b0055","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02962.x","article-title":"Molecular characterization of the family of choline transporter-like proteins and their splice variants","volume":"92","author":"Traiffort","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajcnut.2023.10.003","article-title":"Polymorphisms in the choline transporter SLC44A1 are associated with reduced cognitive performance in normotypic but not prenatal alcohol-exposed children","volume":"119","author":"Smith","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0065","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216320","article-title":"Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype","volume":"15","author":"Koehl","year":"2023","journal-title":"EMBO Mol. Med."},{"issue":"18","key":"10.1016\/j.bcp.2025.117343_b0070","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1021\/jm400966v","article-title":"Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2","volume":"56","author":"Hendrickx","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117343_b0075","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/ijms23042007","article-title":"Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1","volume":"23","author":"Jensen","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.bcp.2025.117343_b0080","doi-asserted-by":"crossref","first-page":"12403","DOI":"10.1021\/acs.jmedchem.2c01075","article-title":"Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2","volume":"65","author":"Gebauer","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2025.117343_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111664","article-title":"Atypical substrates of the organic cation transporter 1","volume":"12","author":"Redeker","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.bcp.2025.117343_b0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117343_b0095","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0022-2275(20)31978-7","article-title":"Functional expression of a high affinity mammalian hepatic choline\/organic cation transporter","volume":"41","author":"Sinclair","year":"2000","journal-title":"J. Lipid Res."},{"issue":"8016","key":"10.1016\/j.bcp.2025.117343_b0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-024-07444-7","article-title":"Molecular mechanism of choline and ethanolamine transport in humans","volume":"630","author":"Ri","year":"2024","journal-title":"Nature"},{"issue":"8012","key":"10.1016\/j.bcp.2025.117343_b0105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41586-024-07326-y","article-title":"Structural and molecular basis of choline uptake into the brain by FLVCR2","volume":"629","author":"Cater","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41422-023-00923-y","article-title":"MFSD7c functions as a transporter of choline at the blood-brain barrier","volume":"34","author":"Nguyen","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2025.117343_b0115","doi-asserted-by":"crossref","unstructured":"D.G. Calame, J.H. Wong, P. Panda, D.T. Nguyen, N.C.P. Leong, R. Sangermano, S.G. Patankar, M. Abdel-Hamid, L. AlAbdi, S. Safwat, K.P. Flannery, Z. Dardas, J.M. Fatih, C. Murali, V. Kannan, T.E. Lotze, I. Herman, F. Ammouri, B. Rezich, S. Efthymiou, S. Alavi, D. Murphy, Z. Firoozfar, M.E. Nasab, A. Bahreini, M. Ghasemi, N.A. Haridy, H.R. Goldouzi, F. Eghbal, E.G. Karimiani, V.M. Srinivasan, V.K. Gowda, H. Du, S.N. Jhangiani, Z. Coban-Akdemir, D. Marafi, L. Rodan, S. Isikay, J.A. Rosenfeld, S. Ramanathan, M. Staton, C.O. Kerby, R.D. Clark, C. Wenman, S. Loughlin, R. Saad, T. Ashraf, A. Male, S. Tadros, R. Boostani, G.M.H. Abdel-Salam, M. Zaki, E. Abdalla, M.C. Manzini, D. Pehlivan, J.E. Posey, R.A. Gibbs, H. Houlden, F.S. Alkuraya, K. Bujakowska, R. Maroofian, J.R. Lupski, L.N. Nguyen, Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders, medRxiv : the preprint server for health sciences (2024).","DOI":"10.1101\/2024.02.09.24302464"},{"issue":"8","key":"10.1016\/j.bcp.2025.117343_b0120","first-page":"4081","article-title":"Deficiency of MFSD7c results in microcephaly-associated vasculopathy in Fowler syndrome","volume":"130","author":"Kalailingam","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2025.117343_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107629","article-title":"Several orphan solute carriers functionally identified as organic cation transporters: Substrates specificity compared with known cation transporters","volume":"300","author":"Redeker","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"6220","key":"10.1016\/j.bcp.2025.117343_b0130","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"10","key":"10.1016\/j.bcp.2025.117343_b0135","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bcp.2012.01.032","article-title":"The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1","volume":"83","author":"Saadatmand","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117343_b0140","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Dos Santos Pereira","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.bcp.2025.117343_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116188","article-title":"Targeted mutagenesis of negatively charged amino acids outlining the substrate translocation path within the human organic cation transporter 3","volume":"223","author":"Redeker","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117343_b0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/d41573-020-00056-6","article-title":"The RESOLUTE consortium: unlocking SLC transporters for drug discovery, Nature reviews","volume":"19","author":"Superti-Furga","year":"2020","journal-title":"Drug Discov."},{"key":"10.1016\/j.bcp.2025.117343_b0155","article-title":"Cellular uptake of psychostimulants - are high- and low-affinity organic cation transporters drug traffickers?","volume":"11","author":"Jensen","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2025.117343_b0165","series-title":"U.S. Department of Health and Human Services, Food and Drug Administration","article-title":"In vitro metabolism and transporter-mediated drug-drug interaction studies - guidance for industry","author":"FDA","year":"2017"},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0170","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1006\/bbrc.2000.3561","article-title":"Molecular cloning of a human, hemicholinium-3-sensitive choline transporter","volume":"276","author":"Apparsundaram","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41421-024-00731-7","article-title":"Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1","volume":"10","author":"Xue","year":"2024","journal-title":"Cell Discov."},{"issue":"7","key":"10.1016\/j.bcp.2025.117343_b0180","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00702-008-0049-0","article-title":"MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake","volume":"115","author":"Takashina","year":"2008","journal-title":"J. Neural Transm. (Vienna, Austria : 1996)"},{"issue":"7","key":"10.1016\/j.bcp.2025.117343_b0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00702-008-0053-4","article-title":"MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats","volume":"115","author":"Bessho","year":"2008","journal-title":"J. Neural Transm. (Vienna, Austria : 1996)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.118.015578","article-title":"Organic cation transporters in health and disease","volume":"72","author":"Koepsell","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-015-0172-0","article-title":"Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1","volume":"7","author":"Seitz","year":"2015","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117343_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21921","article-title":"Circulating choline and phosphocholine measurement by a hydrophilic interaction liquid chromatography-tandem mass spectrometry","volume":"9","author":"Guerra","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1124\/dmd.120.000115","article-title":"Functional investigation of solute carrier family 35, member F2, three cellular models of the primate blood-brain barrier","volume":"49","author":"Mochizuki","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"15","key":"10.1016\/j.bcp.2025.117343_b0210","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jacc.2014.01.007","article-title":"Genetic implication of a novel thiamine transporter in human hypertension","volume":"63","author":"Zhang","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2025.117343_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.854397","article-title":"SLC38A10 regulate glutamate homeostasis and modulate the AKT\/TSC2\/mTOR pathway in mouse primary cortex cells","volume":"10","author":"Tripathi","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117343_b0220","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.neurobiolaging.2004.02.016","article-title":"Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients","volume":"25","author":"Walter","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/cclm-2012-0559","article-title":"Choline-containing phospholipids: relevance to brain functional pathways","volume":"51","author":"Tayebati","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8012","key":"10.1016\/j.bcp.2025.117343_b0230","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41586-024-07374-4","article-title":"Structural basis of lipid head group entry to the Kennedy pathway by FLVCR1","volume":"629","author":"Son","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0235","first-page":"110","article-title":"Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer","volume":"61","author":"DeGrado","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117343_b0240","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nucmedbio.2014.12.019","article-title":"18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision","volume":"42","author":"Evangelista","year":"2015","journal-title":"Nucl. Med. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117343_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071537","article-title":"Drugs that Induce or Cause Deterioration of Myasthenia Gravis: an Update","volume":"10","author":"Sheikh","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117343_b0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1997.00440250045006","article-title":"Drugs and myasthenia gravis. An update","volume":"157","author":"Wittbrodt","year":"1997","journal-title":"Archiv. Internal Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117343_b0255","first-page":"307","article-title":"Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis","volume":"11","author":"Lee","year":"1987","journal-title":"Proc. Natl. Sci. Council, Repub. China. Part B, Life Sci."},{"key":"10.1016\/j.bcp.2025.117343_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinform."},{"issue":"5","key":"10.1016\/j.bcp.2025.117343_b0265","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/cpt.442","article-title":"The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition","volume":"100","author":"Wang","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2025.117343_b0270","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","volume":"35","author":"Zhou","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bcp.2025.117343_b0275","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.bcp.2025.117343_b0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2133\/dmpk.24.91","article-title":"Tissue-specific mRNA expression profiles of human solute carrier 35 transporters","volume":"24","author":"Nishimura","year":"2009","journal-title":"Drug Metab. Pharmacokinet."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:19:14Z","timestamp":1761455954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S0006295225006082"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117343","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity of human choline transporters: substrate specificity, kinetic properties, and inhibitor sensitivity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117343"}}